Exelon Raises Capital Plan to $41.7 Billion: Why the Transmission Pivot Changes the Math

Key Takeaways for Exelon Stock as of June 2026

• Analysts rate Exelon stock 4 Buys, 1 Outperform, 16 Holds, and 2 Sells, with a street mean target of $49, implying around 7% upside from the current price of $46.
• TIKR’s mid-case model values Exelon at around $68 by December 2030, implying around 49% total return from current levels, or roughly 9% annualized.
• Exelon stock is undervalued at current levels, with EPS growth guided near the top of its 5% to 7% long-range target through 2029 while the stock trades roughly 7% below the street mean target.
• Exelon raised its four-year capital plan to $41.7 billion and shifted $1.5 billion toward transmission, targeting 16% transmission rate base growth through 2029 amid surging data center demand.

Exelon stock’s $41.7 billion capital plan and a $58 street high target tell two very different stories about the same stock. Explore Exelon’s analyst targets and rate base trajectory on TIKR for free

Exelon Beats Q1 Estimates and Pivots $1.5 Billion Toward Transmission as Data Center Demand Accelerates

Exelon Corporation (EXC), the nation’s largest regulated electric and gas utility, reported Q1 2026 adjusted operating earnings of $0.91 per share following its May 6 earnings call, exceeding the Street estimate of $0.89 per share.

Revenue for the quarter reached $7.24 billion, surpassing the analyst consensus of $6.93 billion.

The company serves more than 10.7 million customers across six fully regulated transmission and distribution utilities spanning Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington D.C.

Exelon reaffirmed its full-year 2026 adjusted operating earnings guidance of $2.81 to $2.91 per share and committed to delivering EPS growth near the top of its 5% to 7% long-range target through 2029.

The headline development was not the beat.

It was the capital plan pivot.

Exelon raised its four-year capital expenditure plan to $41.7 billion and reallocated $1.5 billion toward transmission while pulling back $1.1 billion from distribution spending, targeting 16% transmission rate base growth through 2029.

The move responds directly to surging data center interconnection demand, FERC-approved transmission security agreements now backed by roughly $1 billion in collateral, and a pending $1.9 billion bid on two Illinois transmission projects in the MISO Tranche 2.1 window.

CEO Calvin Butler framed the shift in clear terms on the Q1 earnings call: “Our scale, diversified footprint and capital flexibility allow us to adapt as conditions evolve without losing focus or momentum.”

Butler also announced $350 million in incremental O&M savings targeted for 2027, driven by contractor reductions, AI-driven efficiency programs, and a voluntary separation offering, allowing Exelon to deliver the same earnings trajectory on a restructured cost base.

The company simultaneously withdrew its PECO (Pennsylvania) electric and gas rate cases, a deliberate affordability concession tied to stakeholder pressure and the Pennsylvania governor’s public call for justifiable utility returns.

The PECO withdrawal does not alter the overall earnings guidance, as the capital reallocation toward higher-returning transmission more than offsets the distribution deferral.

Exelon stock’s transmission pivot and $1.9 billion MISO bid are live catalysts. Track Exelon’s capital plan and rate base growth on TIKR for free →

EXC Stock Holds a Hold-Heavy Rating Despite a Consistent EPS Growth Path Through 2029

Exelon stock carries a consensus dominated by Holds, with 16 of 23 covering analysts sitting on the fence, but the forward earnings picture offers a cleaner argument than the rating distribution implies.

Wall Street projects EPS Normalized to rise around 23% year over year for the quarter ending June 2026, following the Q1 figure of $0.91 per share, and estimates for the fiscal year ending December 2026 point toward around $2.82 per share.

For fiscal 2027, consensus estimates project EPS Normalized of around $0.93 per share for the March quarter, reflecting around 2% sequential growth as transmission capital earns into rate base.

The path from $0.91 in Q1 2026 toward the high end of the $2.81 to $2.91 full-year range depends on rate cases clearing in Maryland and Delaware and the steady accretion of rate base growth already underway, all developments already introduced in the Q1 call.

EBITDA tells the capital-intensive story more cleanly: Q1 2026 EBITDA reached $2.56 billion, up 4.8% from the prior-year period, and consensus estimates project EBITDA of around $2.05 billion for Q2 2026, implying around 12% year-over-year growth as transmission earnings compound.

Of the 23 analysts covering Exelon stock, 4 rate it Buy, 1 Outperform, 16 Hold, and 2 Sell, with a street mean target of $49 and a street high of $58.

The mean target implies around 7% upside from the current price of $46, a gap that reflects neither conviction nor alarm but rather the market waiting for the transmission capital to convert into visible earnings accretion.

Is Exelon Stock Undervalued in 2026? TIKR’s $68 Target Rests on One Capital Assumption

TIKR’s mid-case values Exelon at around $68 by December 2030, implying around 49% total return from the current price of $46, or roughly 9% annualized over the next 4.5 years.

The case for that target rests on the transmission rate base growing at the 16% annual pace Exelon’s management affirmed in May 2026, an assumption already embedded in the $41.7 billion capital plan and supported by a MISO Tranche 2.1 bid that, if awarded, would add $1.9 billion in additional transmission capital beyond the existing plan.

Exelon stock’s EBITDA growth trajectory through fiscal 2026 and 2027, where consensus estimates project around 12% year-over-year growth in Q2 2026, provides the earnings power that makes TIKR’s annualized return credible at current entry prices.

The condition that has to hold is regulatory predictability: the Maryland and Delaware rate cases must clear on a reasonable timeline, and the PECO affordability concession must not metastasize into a pattern of deferred recovery across other jurisdictions.

Exelon’s TIKR model targets around $68 by December 2030. Build your own valuation model for EXC on TIKR for free →

Should You Invest in Exelon Corporation?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up Exelon Corporation stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track Exelon Corporation alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Access Professional Tools to Analyze EXC stock on TIKR for Free →

What is the biggest risk to Exelon’s earnings outlook?

Regulatory pressure across Pennsylvania, Maryland, and Delaware represents the primary risk. The PECO rate case withdrawal in Q1 2026 showed that stakeholder affordability concerns can delay capital recovery, and a similar pattern across other jurisdictions could compress the rate base growth that drives the EPS trajectory toward the top of the 5% to 7% range.

What happened to Exelon stock after Q1 2026 earnings?

Exelon stock rose around 1% in pre-market trading after the May 6 report, as the company beat the adjusted EPS estimate of $0.89 with a $0.91 print and beat the revenue estimate of $6.93 billion with $7.24 billion in actual revenue. The bigger market catalyst was the capital plan pivot to $41.7 billion with transmission spending raised by $1.5 billion.

How does Exelon’s $41.7 billion capital plan affect its dividend?

Exelon management targets 5% annual dividend growth through 2029, with the quarterly dividend standing at $0.42 per share declared for June 2026, implying a payout ratio of around 60%. The transmission-weighted capital plan generates regulated returns that support dividend coverage, as EBITDA growth of around 12% year over year in Q2 2026 estimates exceeds the pace of dividend increase.